Literature DB >> 7566175

Protection against mycoplasma infection using expression-library immunization.

M A Barry1, W C Lai, S A Johnston.   

Abstract

As is evident from the human immunodeficiency virus epidemic, there is no systematic method for producing a vaccine. Genetic immunization is a new approach to vaccine production that has many of the advantages of live/attenuated pathogens but no risk of infection. It involves introducing DNA encoding a pathogen protein into host cells and has shown promise in several disease models. Here we describe a new method for vaccine development, expression-library immunization, which makes use of the technique of genetic immunization and the fact that all the antigens of a pathogen are encoded in its DNA. An expression library of pathogen DNA is used to immunize a host thereby producing the effects of antigen presentation of a live vaccine without the risk. We show that even partial expression libraries made from the DNA of Mycoplasma pulmonis, a natural pathogen in rodents, provide protection against challenge from the pathogen. Expression library immunization may prove to be a general method for vaccination against any pathogen.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7566175     DOI: 10.1038/377632a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  47 in total

Review 1.  Strategies for improving responses to DNA vaccines.

Authors:  J S Boyle; I G Barr; A M Lew
Journal:  Mol Med       Date:  1999-01       Impact factor: 6.354

2.  Pathogens and parasites: strategies and challenges.

Authors:  G G Dimijian
Journal:  Proc (Bayl Univ Med Cent)       Date:  2000-01

Review 3.  Expression library immunization: a road map for discovery of vaccines against infectious diseases.

Authors:  Adel M Talaat; Katherine Stemke-Hale
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

4.  Phage library screening for the rapid identification and in vivo testing of candidate genes for a DNA vaccine against Mycoplasma mycoides subsp. mycoides small colony biotype.

Authors:  John B March; Catherine D Jepson; Jason R Clark; Makrina Totsika; Michael J Calcutt
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

5.  Identification of vaccine candidates for experimental visceral leishmaniasis by immunization with sequential fractions of a cDNA expression library.

Authors:  P C Melby; G B Ogden; H A Flores; W Zhao; C Geldmacher; N M Biediger; S K Ahuja; J Uranga; M Melendez
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

6.  Quantitative analysis of the immunopotency of genetically transfected dendritic cells.

Authors:  L Timares; A Takashima; S A Johnston
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-27       Impact factor: 11.205

Review 7.  Microbial genome sequencing-beyond the double helix.

Authors:  P J Jenks
Journal:  BMJ       Date:  1998-12-05

Review 8.  Coccidioidomycosis: host response and vaccine development.

Authors:  Rebecca A Cox; D Mitchell Magee
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

9.  The tuberculosis epidemic. Scientific challenges and opportunities.

Authors:  A M Ginsberg
Journal:  Public Health Rep       Date:  1998 Mar-Apr       Impact factor: 2.792

10.  The temporal expression profile of Mycobacterium tuberculosis infection in mice.

Authors:  Adel M Talaat; Rick Lyons; Susan T Howard; Stephen Albert Johnston
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-18       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.